Carcinosarcoma

• CLINICAL_TRIALS research · 2026-02-05
  Clinical Trial Update: GISAR German Interdisciplinary Sarcoma Registry

  GISAR is a German interdisciplinary sarcoma registry currently recruiting participants to collect data on various sarcoma types, including s…

• CLINICAL_TRIALS withdrawal · 2025-11-28
  Clinical Trial Update: (VELA) Study of BLU-222 in Advanced Solid Tumors [Phase 1]

  A Phase 1 study of BLU-222 in advanced solid tumors has been terminated.

• CLINICAL_TRIALS research · 2025-08-03
  Clinical Trial Update: Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

  Expanded-access update for Leap Therapeutics' DKN-01 in advanced solid tumors, noting the program is no longer available and targeting multi…

• CLINICAL_TRIALS research · 2024-11-15
  Clinical Trial Update: Pazopanib Vs. Pazopanib Plus Gemcitabine [Phase 2]

  A Phase 2 trial comparing pazopanib alone versus pazopanib plus gemcitabine for leiomyosarcoma or carcinosarcoma is currently active but not…

• CLINICAL_TRIALS trial_result · 2023-06-09
  Clinical Trial Update: A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma [Phase 2]

  Phase 2 study of DKN-01 as a monotherapy or with paclitaxel in recurrent epithelial endometrial cancer, epithelial ovarian cancer, or carcin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-03-04
  Clinical Trial Update: Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma [Phase 2]

  Phase 2 clinical trial evaluating camrelizumab in combination with apatinib for advanced sarcomatoid carcinoma or carcinosarcoma; current st…

• CLINICAL_TRIALS trial_result · 2022-03-02
  Clinical Trial Update: Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? [Phase 2]

  Phase 2 trial investigating cediranib with paclitaxel or cediranib with olaparib for advanced endometrial cancer; status unavailable.